quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:18:55·107d
INSIDERFiling
Sana Biotechnology Inc. logo

Director Bishop Hans Edgar was granted 6,157 shares, increasing direct ownership by 0.11% to 5,840,740 units (SEC Form 4)

SANA· Sana Biotechnology Inc.
Health Care
Original source

Companies

  • SANA
    Sana Biotechnology Inc.
    Health Care

Recent analyst ratings

  • Sep 24UpdateWedbush$5.00
  • Jul 3UpdateMorgan Stanley$12.00
  • Mar 18UpdateCitizens JMP$5.00
  • Mar 14UpdateJefferies$7.00
  • Jan 8UpdateTD Cowen-
  • Nov 5UpdateJMP Securities-

Related

  • SEC5h
    SEC Form DEFA14A filed by Sana Biotechnology Inc.
  • SEC6h
    SEC Form DEF 14A filed by Sana Biotechnology Inc.
  • SEC6h
    Sana Biotechnology Inc. filed SEC Form 8-K: Leadership Update
  • SEC10d
    SEC Form 424B5 filed by Sana Biotechnology Inc.
  • SEC10d
    Sana Biotechnology Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR10d
    Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
  • INSIDER15d
    SEC Form 4 filed by Bishop Hans Edgar
  • PR17d
    Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022